We were also successful in performing CRISPR-Cas9 gene editing of RPTOR (mTORC1) or RICTOR (mTORC2) in IPF fibroblasts as evidenced by marked reduction in Raptor and Rictor protein expression (Fig. 7d). Here, RICTOR is linked to idiopathic pulmonary fibrosis.